Income Statement Guided Therapeutics, Inc.

Stocks

GTHP

US40171F5017

Advanced Medical Equipment & Technology

Market Closed - OTC Markets 09:42:26 29/05/2026 pm IST			5-day change	1st Jan Change
0.2290 ^USD	-.--%		-8.40%	-57.59%

09/09	Guided Therapeutics, Inc. and Türkiye Ministry of Health Reach Collaborative Agreement for Primary Screening Test for Cervical Cancer	CI
13/08	Guided Therapeutics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI

3ec4eb2309d7e39b5ad45d6dcb6bc98b.f706uppYj2PcNLQaNRxlqb4FBStVhPXg3FFeW2E9F7c.SsdD1fU_2lqWA9dCY2Q8-Y9tUm4Ut5SBsxIuPzcKU8MpxHmM9Qr4LuhC4Q

Published financial data: GUIDED THERAPEUTICS, INC.

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2021 (USD)	2022 (USD)	2023 (USD)	2024 (USD)	2025 (USD)
Revenues	81T	13T	98T	7T	8L
Total Revenues	81T	13T	98T	7T	8L
Cost of Goods Sold, Total	61T	81T	62T	5T	2L
Gross Profit	20T	-68T	36T	2T	6L
Selling General & Admin Expenses, Total	23.13L	31.88L	32.65L	15.84L	24.74L
R&D Expenses	69T	77T	2L	5L	5L
Other Operating Expenses, Total	23.82L	32.65L	34.93L	21.1L	29.43L
Operating Income	-23.62L	-33.33L	-34.57L	-21.08L	-23.72L
Interest Expense, Total	-11.5L	-6L	-3L	-4L	-6L
Interest And Investment Income	-	-	6T	3T	-
Net Interest Expenses	-11.5L	-6L	-3L	-4L	-6L
Other Non Operating Income (Expenses)	9L	43T	44T	0	2L
EBT, Excl. Unusual Items	-26.48L	-38.72L	-36.85L	-24.86L	-27.59L
Other Unusual Items	6L	-5L	2L	69T	-4L
EBT, Incl. Unusual Items	-20.7L	-43.41L	-34.89L	-24.17L	-31.96L
Earnings From Continuing Operations	-20.7L	-43.41L	-34.89L	-24.17L	-31.96L
Net Income to Company	-20.7L	-43.41L	-34.89L	-24.17L	-31.96L
Net Income - (IS)	-20.7L	-43.41L	-34.89L	-24.17L	-31.96L
Preferred Dividend and Other Adjustments	4L	6L	3L	2L	2L
Net Income to Common Incl Extra Items	-24.31L	-49.72L	-37.59L	-25.91L	-33.46L
Net Income to Common Excl. Extra Items	-24.31L	-49.72L	-37.59L	-25.91L	-33.46L
Per Share Items
Net EPS - Basic	-0.18	-0.15	-0.07	-0.05	-0.04
Basic EPS - Continuing Operations	-0.18	-0.15	-0.07	-0.05	-0.04
Basic Weighted Average Shares Outstanding	1.34Cr	3.25Cr	5.11Cr	5.73Cr	7.84Cr
Net EPS - Diluted	-0.18	-0.15	-0.07	-0.05	-0.04
Diluted EPS - Continuing Operations	-0.18	-0.15	-0.07	-0.05	-0.04
Diluted Weighted Average Shares Outstanding	1.34Cr	3.25Cr	5.11Cr	5.73Cr	7.84Cr
Normalized Basic EPS	-0.12	-0.07	-0.05	-0.03	-0.02
Normalized Diluted EPS	-0.12	-0.07	-0.05	-0.03	-0.02
Supplemental Items
EBITDA	-23.61L	-33.29L	-34.48L	-20.99L	-23.62L
EBITA	-23.62L	-33.33L	-34.57L	-21.08L	-23.72L
EBIT	-23.62L	-33.33L	-34.57L	-21.08L	-23.72L
EBITDAR	-	-	-	-	-23.49L
Normalized Net Income	-16.55L	-24.2L	-23.03L	-15.54L	-17.24L
Supplemental Operating Expense Items
Selling and Marketing Expenses	1L	2L	3L	3L	2L
General and Administrative Expenses	21.72L	30.07L	29.97L	12.97L	22.92L
Research And Development Expense From Footnotes	69T	77T	2L	5L	5L
Net Rental Expense, Total	-	-	-	-	12.9T
Imputed Operating Lease Interest Expense	-	-	-	-	24.98T
Imputed Operating Lease Depreciation	-	-	-	-	-12.08T
Stock-Based Comp., G&A Exp. (Total)	7L	12.05L	7L	-	3L
Stock-Based Comp., Other (Total)	2L	2L	10.67L	1L	80.19T
Total Stock-Based Compensation	9L	13.81L	18.06L	1L	4L

Fiscal Period: December	2021 (USD)	2022 (USD)	2023 (USD)	2024 (USD)	2025 (USD)
Assets
Cash And Equivalents	6L	23.13L	6L	4L	63T
Total Cash And Short Term Investments	6L	23.13L	6L	4L	63T
Accounts Receivable, Total	46T	6T	7T	3T	4T
Total Receivables	46T	6T	7T	3T	4T
Inventory	6L	5L	6L	6L	4L
Other Current Assets, Total	4L	1L	2L	2L	90T
Total Current Assets	16.37L	30.04L	13.93L	11.97L	6L
Gross Property Plant And Equipment	21.33L	20.95L	18.41L	17.55L	23.02L
Accumulated Depreciation	-17.47L	-17.5L	-15.82L	-15.91L	-16L
Net Property Plant And Equipment	4L	3L	3L	2L	7L
Other Long-Term Assets, Total	17T	17T	17T	17T	17T
Total Assets	20.4L	33.66L	16.69L	13.78L	13.24L
Liabilities
Accounts Payable, Total	24.49L	22.25L	20.23L	21.3L	24.47L
Accrued Expenses, Total	10.68L	10L	7L	8L	15.23L
Short-term Borrowings	8L	3L	59T	1L	11.97L
Current Portion of Long-Term Debt	2L	5L	12.42L	18.02L	10.03L
Current Portion of Leases	67T	79T	91T	1L	45T
Unearned Revenue Current, Total	3L	5L	4L	8L	2L
Other Current Liabilities	7L	3L	2L	3L	2L
Total Current Liabilities	56.94L	48.69L	48.09L	61.55L	66.36L
Long-Term Debt	14.34L	11.29L	5L	63T	43T
Long-Term Leases	3L	2L	2L	49T	7L
Other Non Current Liabilities	32T	5T	-	-	-
Total Liabilities	74.85L	62.49L	54.75L	62.67L	73.3L
Preferred Stock Convertible	68.71L	30.81L	30.2L	29.99L	16.18L
Total Preferred Equity	68.71L	30.81L	30.2L	29.99L	16.18L
Common Stock, Total	34.03L	34.37L	34.41L	34.52L	34.71L
Additional Paid In Capital	13Cr	14Cr	14Cr	14Cr	15Cr
Retained Earnings	-14Cr	-15Cr	-15Cr	-15Cr	-16Cr
Treasury Stock	-1L	-1L	-1L	-1L	-1L
Total Common Equity	-1.23Cr	-59.64L	-68.26L	-78.88L	-76.24L
Total Equity	-54.45L	-28.83L	-38.06L	-48.89L	-60.06L
Total Liabilities And Equity	20.4L	33.66L	16.69L	13.78L	13.24L
Supplemental Items
ECS Total Shares Outstanding on Filing Date	2.21Cr	5.05Cr	5.56Cr	7.8Cr	9.64Cr
ECS Total Common Shares Outstanding	1.37Cr	4.86Cr	5.41Cr	6.51Cr	8.62Cr
Book Value / Share	-0.9	-0.12	-0.13	-0.12	-0.09
Tangible Book Value	-1.23Cr	-59.64L	-68.26L	-78.88L	-76.24L
Tangible Book Value Per Share	-0.9	-0.12	-0.13	-0.12	-0.09
Total Debt	28.99L	22.63L	20.58L	21.59L	29.39L
Net Debt	22.56L	-50T	14.67L	17.71L	28.76L
Debt Equivalent Oper. Leases	-	-	-	-	1L
Account Code - Inventory Valuation	5	5	5	5	5
Inventories - Raw Materials, Total	12.55L	12.6L	13.6L	13.62L	11.91L
Inventories - Work In Process, Total	69T	68T	46T	46T	71T
Inventories - Finished Goods, Total	32T	38T	44T	43T	4T
Machinery, Total	10.89L	11.24L	10L	10L	10L
Full Time Employees	5	6	4	4	3
Accumulated Allowance for Doubtful Accounts (Supple)	1L	48T	2T	500	4T

Fiscal Period: December	2021 (USD)	2022 (USD)	2023 (USD)	2024 (USD)	2025 (USD)
Net Income	-20.7L	-43.41L	-34.89L	-24.17L	-31.96L
Depreciation & Amortization - CF	83T	72T	85T	95T	1L
Depreciation & Amortization, Total	83T	72T	85T	95T	1L
Amortization of Deferred Charges, Total - (CF)	3L	1L	1L	93T	2L
Stock-Based Compensation (CF)	2L	2L	18.06L	1L	4L
Provision and Write-off of Bad Debts	-	23T	2T	-	6T
Other Operating Activities, Total	-2L	19L	-2L	-13T	4L
Change In Accounts Receivable	-22T	16T	-3T	6T	-7T
Change In Inventories	33T	-58T	-84T	-1T	2L
Change In Accounts Payable	1L	1L	43T	5L	13.63L
Change in Unearned Revenues	3L	2L	-85T	4L	-7L
Change in Other Net Operating Assets	-4L	3L	24T	28T	1L
Cash from Operations	-15.92L	-14.78L	-17.46L	-11.19L	-10.68L
Capital Expenditure	-14T	-31T	-	-	-2T
Cash from Investing	-14T	-31T	-	-	-2T
Short Term Debt Issued, Total	-	-	-	75T	-
Long-Term Debt Issued, Total	12.48L	-	-	5L	7L
Total Debt Issued	12.48L	-	-	6L	7L
Short Term Debt Repaid, Total	-14.68L	-5L	-4L	-39T	-
Long-Term Debt Repaid, Total	-	-	-	-4L	-5L
Total Debt Repaid	-14.68L	-5L	-4L	-5L	-5L
Issuance of Common Stock	-	19.24L	4L	8L	6L
Issuance of Preferred Stock	21L	-	-	-	-
Repurchase of Preferred Stock	-1L	-	-	-	-
Other Financing Activities, Total	3L	17.96L	-	-29T	-30T
Cash from Financing	20.67L	31.8L	24T	9L	7L
Net Change in Cash	5L	16.71L	-17.22L	-2L	-3L
Supplemental Items
Cash Interest Paid	6L	1L	1L	51T	61T
Levered Free Cash Flow	-22.04L	-11.52L	-10L	-7L	-6L
Unlevered Free Cash Flow	-18.13L	-9L	-9L	-5L	-5L
Change In Net Working Capital	12.98L	3L	7L	-6L	-6L
Net Debt Issued / Repaid	-2L	-5L	-4L	1L	2L

Fiscal Period: December	2021 (USD)	2022 (USD)	2023 (USD)	2024 (USD)	2025 (USD)
Profitability
Return on Assets	-87.09	-77.07	-85.82	-86.48	-109.73
Return on Total Capital	32.82	131.59	182.49	57.58	51.15
Return On Equity %	25.4	104.25	104.32	55.6	58.67
Return on Common Equity	18.78	54.4	58.78	35.22	43.14
Margin Analysis
Gross Profit Margin %	24.69	-523.08	36.73	28.57	74.45
SG&A Margin	2.86T	24.52T	3.33T	22.63T	322.56
EBITDA Margin %	-2.91T	-25.61T	-3.52T	-29.99T	-307.95
EBITA Margin %	-2.92T	-25.64T	-3.53T	-30.11T	-309.26
EBIT Margin %	-2.92T	-25.64T	-3.53T	-30.11T	-309.26
Income From Continuing Operations Margin %	-2.56T	-33.39T	-3.56T	-34.53T	-416.69
Net Income Margin %	-2.56T	-33.39T	-3.56T	-34.53T	-416.69
Net Avail. For Common Margin %	-3T	-38.25T	-3.84T	-37.01T	-436.25
Normalized Net Income Margin	-2.04T	-18.62T	-2.35T	-22.2T	-224.82
Levered Free Cash Flow Margin	-2.72T	-8.86T	-1.01T	-9.45T	-77.2
Unlevered Free Cash Flow Margin	-2.24T	-7.16T	-963.9	-7.38T	-58.74
Asset Turnover
Asset Turnover	0.05	0	0.04	0	0.57
Fixed Assets Turnover	0.19	0.04	0.32	0.03	1.77
Receivables Turnover (Average Receivables)	2.31	0.5	15.08	1.4	219.14
Inventory Turnover (Average Inventory)	0.1	0.14	0.11	0.01	0.36
Short Term Liquidity
Current Ratio	0.29	0.62	0.29	0.19	0.09
Quick Ratio	0.12	0.48	0.12	0.06	0.01
Operating Cash Flow to Current Liabilities	-0.28	-0.3	-0.36	-0.18	-0.16
Days Sales Outstanding (Average Receivables)	157.72	730	24.21	261.43	1.67
Days Outstanding Inventory (Average Inventory)	3.52T	2.52T	3.47T	46.3T	1.01T
Average Days Payable Outstanding	33.69T	14.71T	5.31T	1L	75.94T
Cash Conversion Cycle (Average Days)	-30.01T	-11.46T	-1.81T	-80.11T	-74.93T
Long Term Solvency
Total Debt/Equity	-53.24	-78.49	-54.07	-44.16	-48.93
Total Debt / Total Capital	-113.86	-365	-117.73	-79.08	-95.83
LT Debt/Equity	-32.3	-47.69	-17.5	-2.29	-11.56
Long-Term Debt / Total Capital	-69.09	-221.77	-38.1	-4.1	-22.63
Total Liabilities / Total Assets	366.91	185.65	328.04	454.79	553.63
EBIT / Interest Expense	-2.05	-5.73	-12.44	-5.53	-3.84
EBITDA / Interest Expense	-2.05	-5.72	-12.4	-5.51	-3.81
(EBITDA - Capex) / Interest Expense	-2.07	-5.77	-12.4	-5.51	-3.81
Total Debt / EBITDA	-1.23	-0.68	-0.6	-1.03	-1.25
Net Debt / EBITDA	-0.96	0.02	-0.43	-0.84	-1.22
Total Debt / (EBITDA - Capex)	-1.22	-0.67	-0.6	-1.03	-1.25
Net Debt / (EBITDA - Capex)	-0.95	0.01	-0.43	-0.84	-1.22
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	-20.59	-83.95	653.85	-92.86	10.86T
Gross Profit, 1 Yr. Growth %	-86.01	-440	-152.94	-94.44	28.45T
EBITDA, 1 Yr. Growth %	129	41	3.57	-22.51	12.53
EBITA, 1 Yr. Growth %	124.52	41.11	3.72	-22.44	12.52
EBIT, 1 Yr. Growth %	124.52	41.11	3.72	-22.44	12.52
Earnings From Cont. Operations, 1 Yr. Growth %	641.94	109.71	-19.63	-30.73	32.23
Net Income, 1 Yr. Growth %	641.94	109.71	-19.63	-30.73	32.23
Normalized Net Income, 1 Yr. Growth %	-15.68T	46.22	-4.83	-15.61	10.98
Diluted EPS Before Extra, 1 Yr. Growth %	354.32	-15.83	-51.94	-31.99	-14.66
Accounts Receivable, 1 Yr. Growth %	91.67	-86.96	16.67	-57.14	33.33
Inventory, 1 Yr. Growth %	-5.62	-4.03	15.33	0.16	-29.23
Net Property, Plant and Equip., 1 Yr. Growth %	-14.98	-10.62	-24.93	-36.68	328.05
Total Assets, 1 Yr. Growth %	51.11	65	-50.42	-17.44	-3.92
Tangible Book Value, 1 Yr. Growth %	-9.28	-51.57	14.45	15.56	-3.35
Common Equity, 1 Yr. Growth %	-9.28	-51.57	14.45	15.56	-3.35
Cash From Operations, 1 Yr. Growth %	-15.09	-7.16	18.05	-35.91	-4.56
Capital Expenditures, 1 Yr. Growth %	1.3T	121.43	-	-	-
Levered Free Cash Flow, 1 Yr. Growth %	-12.8	-59.84	-14.19	54.44	-8.14
Unlevered Free Cash Flow, 1 Yr. Growth %	-23.28	-62.41	1.45	34.28	-12.78
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	50	-64.3	9.99	-26.62	179.76
Gross Profit, 2 Yr. CAGR %	-23.3	-31.04	34.16	-82.85	298.26
EBITDA, 2 Yr. CAGR %	60.55	79.69	20.85	-20.59	-6.62
EBITA, 2 Yr. CAGR %	58.77	78	20.98	-20.47	-6.58
EBIT, 2 Yr. CAGR %	58.77	78	20.98	-20.47	-6.58
Earnings From Cont. Operations, 2 Yr. CAGR %	3.81	294.45	29.83	-25.38	-4.29
Net Income, 2 Yr. CAGR %	3.81	294.45	29.83	-25.38	-4.29
Normalized Net Income, 2 Yr. CAGR %	17.41	1.41T	17.97	-19.87	-3.22
Diluted EPS Before Extra, 2 Yr. CAGR %	-44.11	95.55	-36.4	-42.83	-23.82
Accounts Receivable, 2 Yr. CAGR %	88.11	-50	-60.99	-29.29	-24.41
Inventory, 2 Yr. CAGR %	244.9	-4.83	5.21	7.48	-15.81
Net Property, Plant and Equip., 2 Yr. CAGR %	71	-12.83	-18.09	-31.05	64.63
Total Assets, 2 Yr. CAGR %	31.48	57.9	-9.55	-36.02	-10.93
Tangible Book Value, 2 Yr. CAGR %	-16.68	-33.72	-25.55	15	5.68
Common Equity, 2 Yr. CAGR %	-16.68	-33.72	-25.55	15	5.68
Cash From Operations, 2 Yr. CAGR %	40.54	-11.22	4.72	-13.02	-21.79
Capital Expenditures, 2 Yr. CAGR %	-	456.78	-	-	-
Levered Free Cash Flow, 2 Yr. CAGR %	132.39	-32.49	-41.3	-24.21	17.57
Unlevered Free Cash Flow, 2 Yr. CAGR %	155.68	-37.23	-38.25	-25.52	8.22
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	12.43	-28.79	-1.32	-55.79	289.3
Gross Profit, 3 Yr. CAGR %	-14.5	25.99	-36.86	-53.58	103.26
EBITDA, 3 Yr. CAGR %	15.79	53.75	49.54	-3.84	-10.81
EBITA, 3 Yr. CAGR %	15.12	52.65	48.67	-3.72	-10.72
EBIT, 3 Yr. CAGR %	15.12	52.65	48.67	-3.72	-10.72
Earnings From Cont. Operations, 3 Yr. CAGR %	26.77	31.23	132.11	5.3	-9.7
Net Income, 3 Yr. CAGR %	26.77	31.23	132.11	5.3	-9.7
Normalized Net Income, 3 Yr. CAGR %	386.48	26.32	500.71	-2.08	-10.68
Diluted EPS Before Extra, 3 Yr. CAGR %	136.15	-35.94	22.49	-34.96	-34.66
Accounts Receivable, 3 Yr. CAGR %	52.38	-22.72	-33.68	-59.75	-12.64
Inventory, 3 Yr. CAGR %	71.1	125.17	1.47	3.5	-6.5
Net Property, Plant and Equip., 3 Yr. CAGR %	163.91	37.75	-17.06	-24.82	26.72
Total Assets, 3 Yr. CAGR %	105.23	41.82	7.33	-12.26	-26.73
Tangible Book Value, 3 Yr. CAGR %	-9.53	-30.47	-20.48	-13.8	8.53
Common Equity, 3 Yr. CAGR %	-9.53	-30.47	-20.48	-13.8	8.53
Cash From Operations, 3 Yr. CAGR %	5.26	22.4	-2.35	-11.09	-10.28
Capital Expenditures, 3 Yr. CAGR %	-	-	-	-	-59.89
Levered Free Cash Flow, 3 Yr. CAGR %	2.74	41.32	-26.87	-38.67	-19.89
Unlevered Free Cash Flow, 3 Yr. CAGR %	0.89	49.73	-26.34	-40.7	-21.5
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	-33.11	-44.37	11.45	-27.93	49.71
Gross Profit, 5 Yr. CAGR %	-29.15	-24.97	2.38	-43.26	31.9
EBITDA, 5 Yr. CAGR %	-1.89	2.74	17.78	18.04	18.03
EBITA, 5 Yr. CAGR %	-9.17	1.32	17.43	17.61	17.66
EBIT, 5 Yr. CAGR %	-9.17	1.32	17.43	17.61	17.66
Earnings From Cont. Operations, 5 Yr. CAGR %	-12.21	-16.5	27.99	4.7	62.85
Net Income, 5 Yr. CAGR %	-12.21	-16.5	27.99	4.7	62.85
Normalized Net Income, 5 Yr. CAGR %	-7.78	-18.39	176.02	5.29	176.73
Diluted EPS Before Extra, 5 Yr. CAGR %	-	-82.74	39.73	-38.79	1.3
Accounts Receivable, 5 Yr. CAGR %	-	14.87	-11.65	-25.42	-30.12
Inventory, 5 Yr. CAGR %	-5.88	24.66	40.85	67.51	-5.83
Net Property, Plant and Equip., 5 Yr. CAGR %	25.1	47.75	65.28	4.44	9.11
Total Assets, 5 Yr. CAGR %	6.46	52.66	47.88	3.15	-0.39
Tangible Book Value, 5 Yr. CAGR %	3.11	-21.85	-16.31	-14.96	-10.9
Common Equity, 5 Yr. CAGR %	3.11	-21.85	-16.31	-14.96	-10.9
Cash From Operations, 5 Yr. CAGR %	-2.45	5.26	5.05	6.78	-10.65
Capital Expenditures, 5 Yr. CAGR %	-	-	-	-	14.87
Levered Free Cash Flow, 5 Yr. CAGR %	69.16	34.05	-13.43	10.14	-25.19
Unlevered Free Cash Flow, 5 Yr. CAGR %	6.18	-0.55	-11.76	13.24	-28.22